Multidrug resistant bacteria inside a biofilm
The University has been awarded an initial grant of £250K to help develop antibiotics for multidrug-resistant (MDR) bacteria.
Currently, MDR bacteria are one of the most dangerous threats to human health. Typically, MDR bacteria are associated with infections that originated or were acquired in a hospital.
The University’s Centre for Antimicrobial Pharmacodynamics (CAP) has been awarded the funds by Spero Therapeutics (Massachusetts, USA) for the development of a new antibiotic (SPR206).
Antimicrobial pharmacodynamics is the branch of pharmacology that examines how a drug affects bacteria and is a requirement for the development of drug treatments.
Initial research suggests this new antibiotic may be safer and just as effective as colistin, which is currently a last resort for treatment of MDR bacteria in the NHS as it is frequently toxic.
The research will be led by Professor William Hope and Dr Shampa Das.
The discovery of SPR206 and its preclinical development is being supported by the National Institute for Allergy and Infectious Diseases, National Institutes of Health.
Spero Therapeutics is a global, multi-asset, clinical-stage bio-pharmaceutical company. Their mission is to become a leader in the field of antibiotics.
Of the award Professor Hope said: “This funding will help support further work of the CAP, where the principal task is to identify regimens to take into first-in-patient clinical studies.”
For more information about the University’s Centre for Centre for Antimicrobial Pharmacodynamics please visit www.liverpool.ac.uk/apt
For more information about Spero Therapeutics can be found here https://sperotherapeutics.com/about/
You must be logged in to post a comment.
All recent news
How tattoos became fashionable in Victorian England
Name a Seat in new city cultural landmark
Blog: Staying environmentally friendly this Christmas
Complete the British Active Student Survey
Victoria Gallery and Museum joins the Sunflower Lanyard Scheme for people with hidden disabilities
Front page of our News site this morning📰
Name a seat in our new Music Performance Space, the tattoos of Victorian England and on #GE2019 polling day our experts predict the result
Find it all here 👉 https://news.liverpool.ac.uk/
A new international study involving @livuniIIB scientist Dr Michael Berenbrink reveals how oxygen shaped the #evolution of better eyesight in vertebrates http://bit.ly/36pto9p
"There has been a real rigour and depth to the Club’s engagement over the last two years – so it shouldn’t come as a surprise that their plans have been received so well," says @livuniheseltine Prof Michael Parkinson, our Pro-VC for Civic Engagement #EFC https://www.liverpoolecho.co.uk/special-features/huge-vote-confidence-evertons-the-17388328